RxStrategies, Inc. Names Rhodie Smith National Sales Manager
(GlobeNewswire Via Acquire Media NewsEdge) BOCA RATON, Fla., Sept. 4, 2014 (GLOBE NEWSWIRE) -- RxStrategies, Inc. is pleased to announce the appointment of
Rhodie Smith to National Sales Manager. In this new role, Rhodie
joins the RxStrategies' senior leadership team and is responsible
for sales and delivery of customized 340B pharmacy administration
and split billing solutions to the growing 340B marketplace.
"I am very pleased to welcome Rhodie to the RxStrategies' senior
leadership team," said Fenton Markevich, Chief Executive Officer
for RxStrategies. "We look forward to incorporating Rhodie's deep
340B market and product expertise and knowledge for the benefit of
our existing and future clients. We believe Rhodie will be a strong
addition to our market facing team, and that he will help RxS
highlight an enhanced 340B admin and split billing solution to
existing clients and the overall 340B market."
Rhodie joins RxStrategies with acknowledged industry leadership
and an extensive background in market facing roles to the 340B
market. Rhodie is a graduate of University of Johannesburg and an
alum of 340B University.
"RxStrategies has a strong reputation in the marketplace with
both a unique and transparent processing solution, and a
proprietary split billing solution for this complex market," said
Smith. "I am excited to join a growing industry leader. I have
spent my career using a consultative approach and I look forward to
continuing that tradition by providing 340B guidance and insight to
our current and future clients."
About RxStrategies, Inc.
Established in 2003 and headquartered in Boca Raton, Florida,
RxStrategies, Inc. provides accountability, transparency and
value-based solutions for the Federal 340B Drug Pricing Programs.
As a full-service 340B Drug Pricing Program services organization,
RxStrategies provides a diverse range of services to all "Qualified
Entities" and the in-house and/or contract pharmacies, including
340B administration, split billing, orphan drug and audit services.
RxStrategies' "real-time" comprehensive solutions are designed to
meet the challenges of regulatory compliance, patient eligibility,
pharmacy replenishment, program tracking and reporting of the
Federal 340B Drug Pricing Program. To learn more, please visit
CONTACT: Cheryl Musial
Source: RxStrategies, Inc.
2014 GlobeNewswire, Inc.
[ Back To TMCnet.com's Homepage ]